Skip to main content
editorial
. 2021 Mar 3;116(3):659–678. [Article in Portuguese] doi: 10.36660/abc.20210133

Table 1. Indication prioritization for rescheduling cardiovascular imaging examinations according to the phase of the pandemic and COVID-19 risk.

Level of priority Prioritization rationale
High priority
(Consider performing the examination in the next hours or the next 2 to 4 weeks)
  • Acute cardiovascular symptoms or with recent worsening

  • Evaluation before urgent clinical therapy

  • Planning of urgent cardiovascular interventions

  • Safety monitoring of clinical therapy

  • Monitoring after recent invasive or surgical therapy

To be performed regardless of the pandemic phase

Medium priority
  • Progression monitoring of chronic myocardial disease or asymptomatic severe chronic valvular disease

  • Clinical therapies requiring monitoring

  • Monitoring of therapy results

  • Initial assessment of a new and unexplained heart murmur, even if asymptomatic

Defer until the deceleration phase of the pandemic, preferably for patients at low risk for COVID-19

Low priority
  • Routine evaluation of chronic disease in individuals not eligible for clinical, surgical, or invasive therapy

Defer until the control phase of the pandemic for patients at low risk for COVID-19

Adapted from the recommendations of the American Society of Echocardiography.10